Evaluating and Optimizing Critical Quality Attributes During Cell Line Development

Identifying and measuring critical quality attributes (CQAs) early in the cell line development (CLD) process is essential to ensuring product safety and efficacy. Failure to do this may result in drug attrition during late-stage clinical trials or issues with public safety once the product is on the market.

This listicle presents innovative tools that help optimize CQAs measurement during CLD to avoid late-stage setbacks.

Download this listicle to learn more about:

• Quantify protein titer

• Optimize glycosylation profiling

• Detect host-protein impurities